期刊文献+

HPV16E5蛋白在宫颈癌发生中的作用 被引量:5

Current Study on HPV16 E5 Protein in Cervical Cancer
下载PDF
导出
摘要 人乳头瘤病毒16型(HPV16)与宫颈癌密切相关,编码E5蛋白。HPV16 E5蛋白是一种细胞膜整合蛋白,主要分布于高尔基体和内质网。大量研究证明,HPV16 E5蛋白通过影响表皮生长因子受体信号转导途径及环氧化酶2(COX-2)途径的活性,增加宿主细胞的免疫逃避,调节细胞周期,促进细胞转化、增殖,减少细胞凋亡,促进肿瘤中新生血管的形成等机制影响宫颈癌的发生与发展。就HPV16 E5蛋白的分子生物学特点及与宫颈癌细胞增殖侵袭凋亡关系的研究进展进行综述。 HPV16 virus is the most correlative HPV type to cervical cancer and Encoding E5 protein. HPV16 E5 protein as one of membrane integration of proteins,mainly distributed in the golgi apparatus and endoplasmic reticulum. Numerous studies have demonstrated that HPV16 E5 protein regulates cervical cancer cell proliferation and invasion by promoting the activity of the epidermal growth factor receptor signal transduction pathway and COX -2 pathway,increasing the host cell immune evasion ,regulating the cell cycle,promoting cell transformation and reducing cell apoptosis. This paper summarized the research progress of the relationship between the HPV16 E5 protein of molecular biology and invasion of cervical cancer proliferation.
作者 于宇 张淑兰
出处 《国际妇产科学杂志》 CAS 2014年第1期39-42,共4页 Journal of International Obstetrics and Gynecology
关键词 人乳头瘤病毒16 宫颈肿瘤 细胞增殖 细胞凋亡 E5基因 Human papillomavirus 16 Uterine cervical neoplasms Cell proliferation Apoptosis E5 genes
  • 相关文献

参考文献19

  • 1Ganguly N. Human papillo mavirus -16 E5 protein : oncogenie role and therapeutic value [J]. Cell Oncol (Dordr), 2012,35 (2) : 67-76.
  • 2Maufort JP,Shai A,Pitot HC,et ah A role for HPV16 E5 in cervical carcinogenesis [J]. Cancer Res,2010,70(7 ) :2924-2931.
  • 3Suprynowicz FA,Krawczyk E,Hebert JD,et al. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification [J]. J Virol,2010,84(20) : 10619-10629.
  • 4Shigehara K, Sasagawa T, Kawaguchi S, et al. Etiologic role of human papillomavirus infection in bladder carcinoma [J]. Cancer, 201 l, 117 (10) : 2067 -2076.
  • 5Anderson KS,Wong J,D' Souza G,et al. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer [J]. Br J Cancer, 2011,104( 12): 1896-1905.
  • 6Li W,Deng XM,Wang CX,et al. Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells:correlate with TAP-1 expression [J]. Int J Gynecol Cancer, 2010,20(2) : 227-232.
  • 7Vigueron N ,Van den Eynde BJ. Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes [J]. Cell Mol Life Sci ,2011,68(9) : 1503-1520.
  • 8Cullen SP, Brunet M, Martin SJ. Granzynms in cancer and immunity [J]. Cell Death Differ,2010, 17(4):616-623.
  • 9Miura S,Kawana K,Schust DJ,et al. CDld,a sentinel molecule bridging innate and adaptive immunity,is downregulated by the human papillomavirus (HPV) E5 protein :a possible mechanism for immune evasion by HPV [J]. J Virol, 2010,84( 22 ): 11614-11623.
  • 10Melar-New M,Laimins LA. Human papillomaviruses modulate expression of mieroRNA 203 upon epithelial differentiation to control levels of p63 ~roteins [J]. J Virol, 2010,84(10) :5212-5221.

同被引文献73

  • 1de Freitas AC, Gomes Leit-io Mda C, Coimbra EC. Prospects of molecu- larly-targeted therapies for cervical cancer treatment [ J ]. Curr Drug Targets,2015,16( 1 ) :77-91.
  • 2de Freitas AC, Coimbra EC, Leit-io Mda C. Molecular targets of HPV on- coproteins: Potential biomarkers for cervical carcinogenesis [ J ]. Bio- chimica et Biophysica Acta ( BBA ) -Reviews on Cancer, 2014, 1845 (2) :91-103.
  • 3Gmiguly N. Human papillomavirus-16 F.5 protein: oncogenic role and therapeutic value [ J 1. Cellular Oncology, 2012, 35 (2) : 67-76.
  • 4Liao S, Deng D, Zeng D, et al. HPV16 E5 peptide vaccine in treat- ment of cervical cancer in vitro and in vivo [ J ]. Journal of Huazhong U- niversity of Science and Technology [ Medical Sciences- , 2013, 33 (6) :735-742.
  • 5Maufort JP, Shai A, Pitot HC, et al. A role for HPV16 E5 in cervical carcinogenesis[J]. Cancer Research, 2010, 70(7) : 2924-2931.
  • 6Kim MK, Kim HS, Kim SH, et al. Human papiUomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment[ J ]. Biochemi- cal Pharmacology, 2010, 80(12) : 1930-1935.
  • 7Li W, Deng XM, Wang CX, et al. Down-regulation of HLA class I an- tigen in human papillomavirus type 16 E7 expressing HaCaT cells: cor- relate with TAP-1 expression[ J]. International Journal of Gynecological Cancer, 2010, 20(2): 227-232.
  • 8Grabowska AK, Kaufmann AM, Riemer AB. Identification of promiscu- ous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design[J]. Int J Cancer,2015,136( 1 ) :212-224.
  • 9Vigueron N, Van den Eynde BJ. Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes [ J -. Cel- lular and Molecular Life Sciences, 2011, 68 (9) : 1503-1520.
  • 10Campo MS, Graham SV,Cortese MS,et al. HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells [ J ]. Virology, 2010, 407 ( 1 ) : 137-142.

引证文献5

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部